Sage Therapeutics, Inc.
SAGE · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$50 | -$62 | -$96 | -$94 |
| Dep. & Amort. | -$0 | -$1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $9 | $7 | $9 | $14 |
| Change in WC | $25 | -$25 | $21 | -$1 |
| Other Non-Cash | -$43 | -$0 | -$1 | -$2 |
| Operating Cash Flow | -$59 | -$82 | -$67 | -$82 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$69 | -$88 | -$89 | -$102 |
| Inv. Sales/Matur. | $150 | $134 | $135 | $183 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $81 | $46 | $47 | $81 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $0 | -$0 | $1 |
| Financing Cash Flow | -$0 | $0 | -$0 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $22 | -$36 | -$20 | $1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $47 | $82 | $102 | $101 |
| End Cash | $69 | $47 | $82 | $102 |
| Free Cash Flow | -$59 | -$82 | -$67 | -$82 |